Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
22.12.2023
Opening of a physiotherapy room in Chuna District Hospital with the participation of the Pharmasyntez Group of Companies
Read more
19.12.2023
The Pharmasyntez Group of Companies ranked one of the top 3 fast-growing companies in the pharmaceutical market
Read more
06.12.2023
Etorelex® drug is the winner of Russian Pharma Awards® 2023
Read more
05.12.2023
Nomides in new packages with a height chart
Read more
20.11.2023
The Pharmasyntez Group of Companies participated in the International RUSSIA EXPO
Read more
15.11.2023
The Pharmasyntez Group of Companies released the first batch of the nootropic drug– Nooredit
Read more
10.11.2023
The Pharmasyntez Group of Companies took part in the XIV International Interscience Congress – Manage Pain
Read more
06.11.2023
Nikita Punia: “Our goal is to make medications affordable not only on a local level, but also on the level of the worldwide market”
Read more
29.09.2023
The Pharmasyntez Group leads in key segments of the Russian pharmaceutical market
Read more
27.09.2023
The Pharmasyntez Group presented antiretroviral therapy products at the conference “Topical Issues of HIV Infection in Children”
Read more
14.09.2023
The Pharmasyntez Group of Companies took part in a research and practice seminar “Russia’s reproductive potential: versions and contraversions”
Read more
08.09.2023
Saving people’s lives and health for 26 years!
Read more
04.09.2023
“Sacrificing myself for the sake of serving others”
Read more
29.08.2023
The Pharmasyntez Group of Companies at the XI Baikal Forum against HIV infection
Read more
24.07.2023
The Pharmasyntez Group of Companies is in the TOP 3 pharmaceutical companies in terms of supplies in the 1st quarter of 2023
Read more
14.07.2023
Increase in cancer incidence: challenges and statistics
Read more
News:
← предыдущая
1
2
3
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez